Xavier Mariette Selected Research

Abatacept (Orencia)

3/2024	Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study.
11/2023	Evaluation and comparison of oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies.
11/2023	Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
11/2022	Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).
8/2022	Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.
1/2022	Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept.
1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
11/2019	Two-year abatacept retention rate in clinical practice in the French ACTION cohort.
5/2019	Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
1/2019	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xavier Mariette Research Topics

Disease

122	Rheumatoid Arthritis 03/2024 - 06/2002
32	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 01/2006
28	Neoplasms (Cancer) 12/2023 - 02/2002
27	Infections 01/2023 - 07/2002
25	Necrosis 11/2022 - 04/2002
23	Lymphoma (Lymphomas) 12/2023 - 06/2002
22	COVID-19 03/2024 - 01/2021
17	Arthritis (Polyarthritis) 12/2023 - 07/2003
16	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 01/2005
14	Inflammation (Inflammations) 12/2023 - 03/2003
12	Fatigue 11/2021 - 02/2003
10	Multiple Myeloma 11/2023 - 04/2002
10	Rheumatic Diseases (Rheumatism) 07/2021 - 10/2013
9	Pneumonia (Pneumonitis) 11/2023 - 09/2013
9	Vasculitis (Vasculitides) 01/2023 - 12/2007
8	Pain (Aches) 05/2024 - 06/2011
8	Spondylarthropathies 11/2012 - 03/2003
6	Joint Diseases (Joint Disease) 01/2022 - 12/2005
6	Crohn Disease (Crohn's Disease) 10/2020 - 03/2003
5	Connective Tissue Diseases (Connective Tissue Disease) 12/2023 - 10/2012
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 01/2009
5	Virus Diseases (Viral Diseases) 01/2023 - 05/2009
5	Multiple Sclerosis 01/2022 - 03/2012
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 02/2015
5	Psoriatic Arthritis 12/2020 - 10/2006
5	Ankylosing Spondylitis 11/2009 - 10/2006
4	Sjogren's Syndrome (Sjogren Syndrome) 05/2024 - 02/2007
4	Sialadenitis 12/2022 - 09/2015
4	Skin Neoplasms (Skin Cancer) 11/2021 - 07/2017
4	Melanoma (Melanoma, Malignant) 07/2021 - 05/2009
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 02/2004
4	Latent Tuberculosis 02/2018 - 01/2006
4	Tuberculosis (Tuberculoses) 02/2018 - 03/2003
3	Giant Cell Arteritis (Horton Disease) 01/2023 - 12/2014
3	Obesity 01/2023 - 04/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2009
3	Immune System Diseases (Immune Disorders) 12/2021 - 01/2017
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 12/2011
3	Human Influenza (Influenza) 12/2019 - 06/2017
3	Axial Spondyloarthritis 01/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

50	Rituximab (Mabthera)FDA Link 03/2024 - 02/2007
26	AntibodiesIBA 01/2023 - 02/2002
26	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2003
25	Abatacept (Orencia)FDA Link 03/2024 - 05/2009
23	Tumor Necrosis Factor InhibitorsIBA 11/2023 - 12/2006
19	tocilizumab (atlizumab)FDA Link 11/2023 - 06/2010
18	Antirheumatic Agents (DMARD)IBA 03/2023 - 07/2006
17	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 06/2002
17	Adalimumab (Humira)FDA Link 01/2022 - 06/2007
17	Infliximab (Remicade)FDA Link 10/2020 - 03/2003
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2003
14	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2003
14	Etanercept (Enbrel)FDA Link 01/2022 - 07/2003
11	AutoantibodiesIBA 05/2024 - 05/2003
11	GlucocorticoidsIBA 11/2023 - 07/2006
11	Janus Kinase InhibitorsIBA 01/2023 - 06/2017
10	B-Cell Activating FactorIBA 11/2022 - 04/2004
9	InterferonsIBA 01/2023 - 07/2002
9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 06/2012
9	tofacitinibIBA 01/2022 - 06/2017
8	CytokinesIBA 01/2021 - 03/2003
8	SteroidsIBA 01/2021 - 01/2004
8	Rheumatoid FactorIBA 01/2021 - 08/2003
7	Immune Checkpoint InhibitorsIBA 05/2024 - 10/2017
7	Immunosuppressive Agents (Immunosuppressants)IBA 03/2024 - 12/2015
7	Oxygen (Dioxygen)IBA 11/2023 - 01/2021
7	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2012
6	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 07/2014
6	Monoclonal AntibodiesIBA 01/2022 - 10/2008
6	Immunoglobulin G (IgG)IBA 10/2021 - 08/2003
6	Certolizumab Pegol FDA Link 01/2020 - 03/2014
5	Immunologic Factors (Immunomodulators)IBA 03/2024 - 01/2021
5	RNA (Ribonucleic Acid)IBA 08/2023 - 07/2002
5	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 08/2002
4	Janus KinasesIBA 11/2022 - 06/2017
4	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2002
4	Messenger RNA (mRNA)IBA 01/2022 - 05/2009
4	COVID-19 VaccinesIBA 01/2022 - 10/2021
4	Biosimilar PharmaceuticalsIBA 01/2022 - 03/2014
4	baricitinibIBA 01/2022 - 06/2017
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 05/2005
3	EnzymesIBA 12/2023 - 12/2016
3	CollagenIBA 12/2023 - 02/2003
3	C-Reactive ProteinIBA 11/2023 - 12/2007
3	InterleukinsIBA 11/2022 - 07/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 10/2007
3	VaccinesIBA 01/2022 - 06/2017
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 04/2002
3	Interferon Type IIBA 01/2021 - 09/2010
3	TinIBA 12/2020 - 02/2016
3	golimumab FDA Link 01/2020 - 03/2014
3	Interleukin-33IBA 01/2018 - 12/2016

Therapy/Procedure

65	Therapeutics 03/2024 - 07/2003
19	Biological Therapy 01/2022 - 11/2004
11	Immunotherapy 12/2022 - 01/2015
5	Injections 11/2023 - 01/2016
5	Immunomodulation 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 11/2023 - 06/2003
3	Artificial Respiration (Mechanical Ventilation) 04/2022 - 10/2021